Cookies Launches First Medical Cannabis In UK - Data Intelligence
5 Articles
5 Articles
Josh Kesselman, HBI Innovations Founder, Announces RAW’s Win at the 2nd Annual International Cannabis Awards
New York, NY (Newsworthy.ai) Monday Apr 14, 2025 @ 12:15 PM Pacific — Josh Kesselman, founder of HBI Innovations (formerly BBK Tobacco & Foods, LLP dba HBI International), has announced RAW®’s latest victory at the 2nd International Cannabis Awards. HBI Innovations is an independent provider of high-quality rolling papers, cones, and other smoking accessories. RAW® rolling papers won in two separate categories – Best World Wide winner and USA wi…
Mamedica to Become ‘Official Licence Holder and Distributor’ of Cannabis Giant Cookies in the UK - Cannabis News World
Mamedica has today announced an exclusive partnership with Cookies to offer its premium pharmaceutical products to patients across the UK. The post Mamedica to Become ‘Official Licence Holder and Distributor’ of Cannabis Giant Cookies in the UK appeared first on Business of Cannabis.
Cookies Launches First Medical Cannabis In UK - Data Intelligence
People in the UK who are prescribed medical cannabis through a private clinic can now request flower from the global cannabis brand Cookies, according to a press release seen by leafie. The first strain available, Hawaiian Rain, is a high-potency flower containing 31% THC. Priced at £11 a gram, it is the expensive flower available on prescription at the time of publication. Patients prescribed medical cannabis through private clinics and partner…
Mamedica to Become 'Official Licence Holder and Distributor' of Cannabis Giant Cookies in the UK - Business of Cannabis
Mamedica CEO, Jon Robson and Cookies co-founder and CEO, Berner, discuss the impact of this landmark collaboration for access to medical cannabis in the UK Mamedica the nation’s leading medical cannabis clinic, servicing nearly 10,000 patients – has today announced an exclusive partnership with Cookies, the world’s most recognised cannabis brand, to offer its premium pharmaceutical products to patients across the UK. Through this agreement, Mame…
Coverage Details
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage